Table 2:
PFO detected | PFO not detected | p value | |
---|---|---|---|
Patients with recurrent stroke | 20 | 295 | 0·46 |
Topography | |||
Deep only* | 6 (30%) | 100 (34%) | 0·44 |
All others† | 14 (70%) | 158 (54%) | .. |
Subtype | |||
ESUS | 14 (70%) | 144 (49%) | 0·07 |
Non-ESUS | 6 (30%) | 151 (51%) | .. |
Outcome at 7 days or discharge | |||
mRS ≤2 | 16 (80%) | 182 (65%) | 0·16 |
mRS >2 | 4 (20%)‡ | 100 (35%) | .. |
Data are n or n (%), unless otherwise stated. PFO=patent foramen ovale. ESUS=embolic stroke of undetermined source. mRS=modified Rankin Scale score.
Subcortical only or brainstem only.
Any cortical, any cerebellum, multiple, and so on.
Of the four patients with mRS >2, three occurred on rivaroxaban and one on aspirin.